182 related articles for article (PubMed ID: 36810892)
1. Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma.
Wang G; Yang X; Qi M; Li M; Dong M; Xu R; Zhang C
Sci Rep; 2023 Feb; 13(1):3023. PubMed ID: 36810892
[TBL] [Abstract][Full Text] [Related]
2. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma.
Jiang X; Chen X; Huang X; Wang C; Wang C; Pan C; Cho WC; Nie Z; Pu J; Wang W
Aging (Albany NY); 2022 Jun; 14(19):7774-7793. PubMed ID: 35661004
[TBL] [Abstract][Full Text] [Related]
4. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
Li J; Zhang Y; Qu Z; Ding R; Yin X
Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
[TBL] [Abstract][Full Text] [Related]
5. BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma.
Zhao L; Song C; Li Y; Yuan F; Zhao Q; Dong H; Liu B
Genomics; 2023 May; 115(3):110602. PubMed ID: 36907429
[TBL] [Abstract][Full Text] [Related]
6. Low expression of GRM4 is associated with poor prognosis and tumor immune infiltration in glioma.
Fan H; Yan D; Fang X; Xiao L; Liang M; Wu H; Zhu G; Geng D; Liu Q
Int J Neurosci; 2024 Jan; ():1-13. PubMed ID: 38164693
[TBL] [Abstract][Full Text] [Related]
7. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
8. Expression, Significance, and Correlation of Histone Deacetylase 1/RE-1 Silencing Transcription Factor and Neuronal Markers in Glioma.
Shen Y; Ye YR; Tang ZQ
World Neurosurg; 2023 Apr; 172():e267-e277. PubMed ID: 36623722
[TBL] [Abstract][Full Text] [Related]
9. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
10. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
[TBL] [Abstract][Full Text] [Related]
12. The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
Wang Z; Aili Y; Wang Y; Maimaitiming N; Qin H; Ji W; Fan G; Li B
Oxid Med Cell Longev; 2022; 2022():7967722. PubMed ID: 35993018
[TBL] [Abstract][Full Text] [Related]
13. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
Wang X; Huang Y; Li S; Zhang H
Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
[TBL] [Abstract][Full Text] [Related]
14.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
15. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma.
Liao G; Zhang M; Wang C
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3485-3494. PubMed ID: 35951089
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
17. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]